Phase 2 randomized study of p53 antisense oligonucleotide...

Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia

Jorge Cortes, Hagop Kantarjian, Edward D. Ball, John DiPersio, Jonathan E. Kolitz, Hugo F. Fernandez, Mark Goodman, Gautam Borthakur, Maria R. Baer, Meir Wetzler
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
118
Year:
2012
Language:
english
Pages:
10
DOI:
10.1002/cncr.26292
File:
PDF, 229 KB
english, 2012
Conversion to is in progress
Conversion to is failed